MS and Diabetes: Why Blood Sugar Checks May Matter

Credibility

Interest

Share:2 min read

Key Takeaway

In a large English study, people with MS developed diabetes more often than people without MS, and those who developed diabetes had more hospital stays and a higher risk of death.

What They Found

Researchers followed about 47,000 adults with MS and 459,000 adults without MS for about 15 years. No one had diabetes at the start, and the groups were matched by age, sex, and doctor’s office. People with MS developed diabetes about 16% more often than people without MS. Among people with MS, those who developed diabetes had about 52% more hospital stays than those who did not. Their typical hospital stay was 12 days instead of 2, and their risk of death was also higher.

Who Should Care and Why

If you live with MS, this study gives you another reason to talk with your care team about blood sugar, which is the amount of sugar in your blood. Diabetes happens when blood sugar stays too high, and a blood test can help check for it. Ask your healthcare provider whether a blood sugar check makes sense for you and how often you may need one. Caregivers can help by keeping track of test results and bringing questions to appointments. Healthcare providers can use these findings to make diabetes checks and care part of a plan that also addresses MS.

Important Considerations

The study shows a link, but it does not prove that MS causes diabetes or that diabetes caused the hospital stays or deaths. The results came from health records in England, so they may not apply equally to everyone. The study did not test whether more blood sugar checks or a specific treatment would improve outcomes for people with MS.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Progression Living with MS MS Diagnostics

Article Topics:

comorbiditydiabeteshealth inequalitiesmultiple sclerosis

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of clinical and translational neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News